Trending...
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
Merck (NYSE: MRK), a leading global biopharmaceutical company, will invest $57 million and create 55 jobs in Wilson, Governor Roy Cooper announced today. The expansion will establish a filling and packaging line for the company's RotaTeq® vaccine.
"Merck is a cornerstone of pharmaceutical development and manufacturing, and good jobs will continue to grow with today's announcement in Wilson," said Governor Cooper.
Merck, with headquarters in Kenilworth, New Jersey and known as MSD outside of the United States and Canada, discovers and develops medicines and vaccines for many of the world's most challenging diseases. The company operates in more than 140 countries and stays at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world.
The company's RotaTeq® vaccine is used to prevent rotavirus gastroenteritis in children. Rotavirus gastroenteritis can cause fever, vomiting and diarrhea that can be severe and lead to dehydration and hospitalization. Merck's investment at the Wilson site will increase the company's overall supply of this important medicine.
"Merck is delighted to announce its second significant investment at our Wilson plant in less than a year," said Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division. This latest commitment will enable us to introduce a new and innovative filling and packaging technology to assist in the production of our important RotaTeq® vaccine. We appreciate all the support we've received for this project from Governor Cooper, Secretary Copeland and his staff, and from Wilson County."
More on ncarol.com
Today's commitment is the second major expansion Merck has announced in North Carolina in 2019. In July, the company announced it would begin producing its GARDASIL® and GARDASIL 9® recombinant human papillomavirus (HPV) vaccine in the state, supported by expansion of company facilities in Durham and Wilson. In the earlier announcement, the company committed to invest more than $680 million in the state, with $30 million of that investment earmarked for Wilson.
"Nothing beats first-hand knowledge, and Merck's previous experience in our state gave them the confidence to bring this new business line here," said North Carolina Commerce Secretary Anthony M. Copeland. "In just one year, this company has now invested $737 million in North Carolina, proving again that we're a hotbed for the life science industry."
The North Carolina Department of Commerce led the state's support for the company during its site evaluation and decision-making process.
Although wages will vary depending on position, Merck's average salary for all the new positions will reach $59,273. The current average wage in Wilson County is $44,012.
A performance-based grant of $200,000 from the One North Carolina Fund will help facilitate Merck's expansion in Wilson County. The One NC Fund provides financial assistance to local governments to help attract economic investment and to create jobs. Companies receive no money upfront and must meet job creation and capital investment targets to qualify for payment. All One NC grants require a matching grant from local governments and any award is contingent upon that condition being met.
More on ncarol.com
"Merck is a valued employer in our region," said N.C. Senator Milton 'Toby' Fitch, Jr. "We welcome these additional jobs and the opportunities they will bring to our people."
"New growth from one of our area's most important industries is an exciting development," said N.C. Representative Jean Farmer-Butterfield. "Our community is proud to partner with Merck and we look forward to supporting the company's next phase of growth."
Partnering with N.C. Commerce and the Economic Development Partnership of North Carolina on this project were the North Carolina General Assembly, Wilson County, and the Wilson County Economic Development Office.
"Merck is a cornerstone of pharmaceutical development and manufacturing, and good jobs will continue to grow with today's announcement in Wilson," said Governor Cooper.
Merck, with headquarters in Kenilworth, New Jersey and known as MSD outside of the United States and Canada, discovers and develops medicines and vaccines for many of the world's most challenging diseases. The company operates in more than 140 countries and stays at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world.
The company's RotaTeq® vaccine is used to prevent rotavirus gastroenteritis in children. Rotavirus gastroenteritis can cause fever, vomiting and diarrhea that can be severe and lead to dehydration and hospitalization. Merck's investment at the Wilson site will increase the company's overall supply of this important medicine.
"Merck is delighted to announce its second significant investment at our Wilson plant in less than a year," said Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division. This latest commitment will enable us to introduce a new and innovative filling and packaging technology to assist in the production of our important RotaTeq® vaccine. We appreciate all the support we've received for this project from Governor Cooper, Secretary Copeland and his staff, and from Wilson County."
More on ncarol.com
- Burgerfi Set To Open New Restaurant In North Raleigh (wakefield), North Carolina This Winter
- 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
- Mother Launches National Movement After College Athlete Hospitalized During Punishment Workout
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
- Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
Today's commitment is the second major expansion Merck has announced in North Carolina in 2019. In July, the company announced it would begin producing its GARDASIL® and GARDASIL 9® recombinant human papillomavirus (HPV) vaccine in the state, supported by expansion of company facilities in Durham and Wilson. In the earlier announcement, the company committed to invest more than $680 million in the state, with $30 million of that investment earmarked for Wilson.
"Nothing beats first-hand knowledge, and Merck's previous experience in our state gave them the confidence to bring this new business line here," said North Carolina Commerce Secretary Anthony M. Copeland. "In just one year, this company has now invested $737 million in North Carolina, proving again that we're a hotbed for the life science industry."
The North Carolina Department of Commerce led the state's support for the company during its site evaluation and decision-making process.
Although wages will vary depending on position, Merck's average salary for all the new positions will reach $59,273. The current average wage in Wilson County is $44,012.
A performance-based grant of $200,000 from the One North Carolina Fund will help facilitate Merck's expansion in Wilson County. The One NC Fund provides financial assistance to local governments to help attract economic investment and to create jobs. Companies receive no money upfront and must meet job creation and capital investment targets to qualify for payment. All One NC grants require a matching grant from local governments and any award is contingent upon that condition being met.
More on ncarol.com
- Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
- Canterbury Hotel Group Announces the Opening of the TownePlace Suites by Marriott Portland Airport
- Heritage at South Brunswick's Resort-Style Amenities for Any Age and Every Lifestyle
- T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
- Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)
"Merck is a valued employer in our region," said N.C. Senator Milton 'Toby' Fitch, Jr. "We welcome these additional jobs and the opportunities they will bring to our people."
"New growth from one of our area's most important industries is an exciting development," said N.C. Representative Jean Farmer-Butterfield. "Our community is proud to partner with Merck and we look forward to supporting the company's next phase of growth."
Partnering with N.C. Commerce and the Economic Development Partnership of North Carolina on this project were the North Carolina General Assembly, Wilson County, and the Wilson County Economic Development Office.
0 Comments
Latest on ncarol.com
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- 15,000+ Fans Expected at the 2026 BIG HBCU Southern Classic Battle of the Bands in Charlotte
- Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
- Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- Railinc Launches RIGIS Routing+Mileage Application to Provide Accurate & Comprehensive Rail Routing
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
- BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
- "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
- Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
- Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand
- Signature Smiles Dental Group Unveils New User-Friendly Website
- tukr box® Ministries Launches Meal Sharing Kit to Combat Veteran Homelessness
- CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
- QwickContractReview.com Launches $19 Contract Review Service to Protect Consumers from Hidden Contract Risks
- 100% Bonus Depreciation Places New Spotlight on Off The Hook Yacht Sales Inc. (N Y S E: OTH) as a Major Player in the $57 Billion U.S. Marine Market
- CNCPW Benchmarks Global Industry Standards: Integrating SEC Compliance with 3 Million TPS Architecture for Institutional Infrastructure
- The Patina Collective & Artist Jesse Draxler Debut "The Machine of Loving Grace"
- Smile! Dental Center Named 2025 "Best Dentist" in North Pittsburgh, Celebrating High-Tech Care and Heartfelt Service
- Dr. Johnny Shanks, As Seen on TV, Announces 20% Off Dental Implant Treatments | Tennessee's Leading All-on-X Provider